Improving the Safety and Security of Biological Research
- Executive Order Number
- 14292
- President
- Donald Trump
- Signed
- May 5, 2025
- Published
- May 8, 2025
- Source
- Federal Register
- Original Document
- https://www.govinfo.gov/content/pkg/FR-2025-05-08/pdf/2025-08266.pdf
AI-Generated Summary
Executive Order on Stopping Dangerous Gain-of-Function Research
Purpose
The purpose of this executive order is to address the risks associated with gain-of-function (GoF) research on biological agents and pathogens, which can pose significant dangers to public health, economic stability, and national security. The order aims to halt such research, particularly when conducted abroad with insufficient oversight, and to establish robust frameworks for managing and overseeing this type of research in the future.
Key Actions or Directives
- Immediate Suspension of Funding:
- The Director of the Office of Science and Technology Policy (OSTP), in coordination with other key officials, must establish guidance to immediately end federal funding for dangerous GoF research conducted by foreign entities in countries of concern (e.g., China) and other countries without adequate oversight.
- Federal funding for other life-science research in countries of concern that could pose threats to public health, safety, and security must also be terminated.
- Policy Revision:
- Within 120 days, the OSTP must revise or replace the 2024 policy on dual-use research to strengthen oversight, accountability, and transparency while ensuring U.S. leadership in biotechnology.
- Within 90 days, the OSTP must update the 2024 Framework for Nucleic Acid Synthesis Screening to enhance screening mechanisms and minimize misuse risks.
- Non-federally Funded Research:
- Within 180 days, a strategy must be developed to govern, limit, and track dangerous GoF research without federal funding, including comprehensive nucleic acid synthesis screening.
- Accountability and Transparency:
- A reporting mechanism must be established for research institutions receiving federal funding to report dangerous GoF research, including non-federally funded projects, to a publicly accessible database.
- Enforcement:
- New terms must be included in life-science research contracts and grants to enforce compliance with the order, including potential revocation of funding and future ineligibility for grants upon violation.
Significant Changes to Policy or Law
- The order introduces immediate restrictions on federal funding for dangerous GoF research conducted abroad.
- It mandates the revision of existing policies to enhance oversight, accountability, and transparency in GoF and related research.
- It requires the development of a strategy to manage non-federally funded GoF research, which may necessitate new legislative proposals.
Potential Impacts
- Government Agencies:
- Agencies such as the Department of Health and Human Services and the National Institutes of Health will need to adjust their funding and oversight practices significantly.
- New enforcement mechanisms will require additional resources and personnel to implement and monitor compliance.
- Citizens:
- Enhanced safety measures may reduce the risk of pandemics or biological threats, potentially improving public health and security.
- Increased transparency could build public trust in government-funded research.
- International Relations:
- The order may strain relations with countries like China, where U.S. funding for research will be cut.
- It may prompt other nations to review their own policies on GoF research and oversight.
Main Stakeholders Affected
- Federal Agencies: Particularly those involved in funding and overseeing life-science research, such as the OSTP, the Office of Management and Budget, the Department of Health and Human Services, and the National Institutes of Health.
- Research Institutions: Both domestically and internationally, especially those receiving federal funding for life-science research.
- International Governments: Especially those identified as countries of concern, which will see a cessation of U.S. funding for certain types of research.
- Biotech and Life-Science Industry: Companies and researchers involved in GoF and related research will need to adapt to new oversight and funding restrictions.
Notable Legal, Constitutional, or Political Implications
- Legal Implications:
- The order's enforcement terms could lead to legal challenges if institutions or individuals dispute the termination of funding or other penalties.
- The requirement for legislative proposals to address gaps in authority may lead to new laws or amendments to existing ones.
- Constitutional Implications:
- The executive order's scope and immediate actions on funding could raise questions about the separation of powers, particularly if Congress perceives it as an overreach into legislative authority.
- Political Implications:
- The order may be seen as a response to criticisms of previous administrations' handling of GoF research, potentially affecting political discourse on biosecurity and public health.
- It could influence future policy debates on the balance between scientific advancement and national security.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.